Drug-Resistant Tuberculosis

ISBN 10: 1608760553 ISBN 13: 9781608760558
Editorial: Nova Science Publishers Inc, 2010
Nuevos HRD

Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Vendedor de AbeBooks desde 7 de abril de 2005

Este ejemplar en concreto ya no está disponible. Estas algunas de las coincidencias similares para Drug-Resistant Tuberculosis.

Descripción

Descripción:

New Book. Shipped from UK. Established seller since 2000. N° de ref. del artículo GZ-9781608760558

Denunciar este artículo

Sinopsis:

Tuberculosis (TB) is a major public health problem of global proportions. It is the second leading cause of death from an infectious agent, killing nearly two million people each year, mostly in developing countries. This book outlines the recent advances in the development of new multidrug-resistant tuberculosis (MDR-TB) drugs. The emergence of resistance to antituberculosis drugs, particularly of MDR-TB and newly XDR-TB has become a major health problem. This book provides some glimpses into the current drugs including their mechanism of action, side-effects and mechanism of resistance. The desirable features of new drugs is also discussed, as well as different targets for effective TB treatment and approaches that are being made in the development of potential drugs for resistant tuberculosis. The effectiveness of levofloxacin and olfoxacin in the treatment of multi-drug resistant tuberculosis is also comparatively assessed to determine the immunological effects of certain treatment regimens. Finally, this book expands upon the spectrum of potential resistance-related mutations in MTB clinical isolates to help consolidate the framework for the development of molecular methods for delineating the drug susceptibility profiles in clinical laboratories.

Reseña del editor: Tuberculosis (TB) is a major public health problem of global proportions. It is the second leading cause of death from an infectious agent, killing nearly two million people each year, mostly in developing countries. This book outlines the recent advances in the development of new multidrug-resistant tuberculosis (MDR-TB) drugs. The emergence of resistance to antituberculosis drugs, particularly of MDR-TB and newly XDR-TB has become a major health problem. This book provides some glimpses into the current drugs including their mechanism of action, side-effects and mechanism of resistance. The desirable features of new drugs is also discussed, as well as different targets for effective TB treatment and approaches that are being made in the development of potential drugs for resistant tuberculosis. The effectiveness of levofloxacin and olfoxacin in the treatment of multi-drug resistant tuberculosis is also comparatively assessed to determine the immunological effects of certain treatment regimens. Finally, this book expands upon the spectrum of potential resistance-related mutations in MTB clinical isolates to help consolidate the framework for the development of molecular methods for delineating the drug susceptibility profiles in clinical laboratories.

"Sobre este título" puede pertenecer a otra edición de este libro.

Detalles bibliográficos

Título: Drug-Resistant Tuberculosis
Editorial: Nova Science Publishers Inc
Año de publicación: 2010
Encuadernación: HRD
Condición: New

Los mejores resultados en AbeBooks

Existen otras 136 copia(s) de este libro

Ver todos los resultados de su búsqueda